ZYMEWORKS INC. Amortization of Intangible Assets
ZYMEWORKS INC. (ZYME) reported Amortization of Intangible Assets of $352.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- ZYMEWORKS INC. amortization of intangible assets for the quarter ending 2026-06-30 was $176.00K, a 89.04% decline year-over-year.
- ZYMEWORKS INC. amortization of intangible assets for the quarter ending 2026-03-31 was $176.00K, a 89.12% decline year-over-year.
- ZYMEWORKS INC. amortization of intangible assets for the quarter ending 2025-12-31 was $185.00K, a 90.76% decline year-over-year.
- ZYMEWORKS INC. amortization of intangible assets for the quarter ending 2025-09-30 was $648.00K, a 33.88% decline year-over-year.
- ZYMEWORKS INC. amortization of intangible assets for fiscal 2025 was $4.06M, a 9.79% decline from fiscal 2024.
- ZYMEWORKS INC. amortization of intangible assets for fiscal 2024 was $4.50M, a 66.40% increase from fiscal 2023.
- ZYMEWORKS INC. amortization of intangible assets for fiscal 2023 was $2.70M, a 166.21% increase from fiscal 2022.
- ZYMEWORKS INC. amortization of intangible assets for fiscal 2022 was $1.01M, a 63.66% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $352.00K 10-Q · filed 2026-08-06 | $537.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $176.00K 10-Q · filed 2026-05-07 | $361.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.01M derived: sum of 3 quarters · filed 2026-05-07 | $2.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $833.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.44M derived: sum of 3 quarters · filed 2026-08-06 | $4.06M 10-K · filed 2026-03-02 |
| 2025-09-30 | $648.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.25M derived: sum of 2 quarters · filed 2026-08-06 | $3.87M 10-Q · filed 2025-11-06 | $5.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.22M 10-Q · filed 2026-08-06 | $5.22M derived: sum of 3 quarters · filed 2026-08-06 | $6.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.62M 10-Q · filed 2026-05-07 | $3.62M derived: sum of 2 quarters · filed 2026-05-07 | $4.60M derived: sum of 3 quarters · filed 2026-05-07 | $5.41M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $2.98M derived: sum of 2 quarters · filed 2026-03-02 | $3.79M derived: sum of 3 quarters · filed 2026-03-02 | $4.50M 10-K · filed 2026-03-02 |
| 2024-09-30 | $980.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.79M derived: sum of 2 quarters · filed 2025-11-06 | $2.49M 10-Q · filed 2025-11-06 | $3.17M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $812.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.51M 10-Q · filed 2025-08-07 | $2.19M derived: sum of 3 quarters · filed 2026-03-02 | $2.86M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $702.00K 10-Q · filed 2025-05-08 | $1.38M derived: sum of 2 quarters · filed 2026-03-02 | $2.05M derived: sum of 3 quarters · filed 2026-03-02 | $2.73M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.34M derived: sum of 2 quarters · filed 2026-03-02 | $2.02M derived: sum of 3 quarters · filed 2026-03-02 | $2.70M 10-K · filed 2026-03-02 |
| 2023-09-30 | $672.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.35M derived: sum of 2 quarters · filed 2024-10-31 | $2.03M 10-Q · filed 2024-10-31 | $2.56M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $678.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.36M 10-Q · filed 2024-08-01 | $1.89M derived: sum of 3 quarters · filed 2025-03-05 | $2.05M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $679.00K 10-Q · filed 2024-05-02 | $1.21M derived: sum of 2 quarters · filed 2025-03-05 | $1.37M derived: sum of 3 quarters · filed 2025-03-05 | $1.54M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $695.00K derived: sum of 2 quarters · filed 2025-03-05 | $860.00K derived: sum of 3 quarters · filed 2025-03-05 | $1.01M 10-K · filed 2025-03-05 |
| 2022-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $331.00K derived: sum of 2 quarters · filed 2023-11-07 | $486.00K 10-Q · filed 2023-11-07 | $636.00K derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $320.00K 10-Q · filed 2023-08-10 | $470.00K derived: sum of 3 quarters · filed 2024-03-06 | |
| 2022-03-31 | $155.00K 10-Q · filed 2023-05-08 | $305.00K derived: sum of 2 quarters · filed 2024-03-06 | ||
| 2021-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $2.79M 10-K · filed 2024-03-06 | ||
| 2021-09-30 | $2.64M 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $4.16M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |